Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.13M P/E - EPS this Y - Ern Qtrly Grth -
Income -10.42M Forward P/E -0.54 EPS next Y 58.40% 50D Avg Chg -43.00%
Sales 1.98M PEG - EPS past 5Y - 200D Avg Chg -76.00%
Dividend N/A Price/Book 2.08 EPS next 5Y - 52W High Chg -97.00%
Recommedations 2.00 Quick Ratio 0.93 Shares Outstanding 794.95K 52W Low Chg 7.00%
Insider Own 36.62% ROA -76.27% Shares Float 604.13K Beta -
Inst Own 21.73% ROE - Shares Shorted/Prior 74.14K/67.86K Price 2.68
Gross Margin 100.00% Profit Margin - Avg. Volume 1,235,649 Target Price 9.00
Oper. Margin -626.83% Earnings Date - Volume 48,515 Change -7.90%
About TC BioPharm (Holdings) plc

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

TC BioPharm (Holdings) plc News
03/22/23 TC Biopharm Announces Corporate Restructuring, Reduction in Overhead
03/16/23 TC BioPharm Receives Extension from Nasdaq Hearings Panel to Regain Compliance With Listing Rule 5550(b)(2)
03/07/23 TC BioPharm Shifts Focus to FDA Clinical Trials
08:30 AM TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer
02/21/23 TC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies
02/14/23 TC BioPharm Announces New Chair of the Board, Arlene Morris
02/13/23 TC BioPharm to Reschedule Shareholder Update Call and Webcast
02/07/23 TC BioPharm Announces Successful Dosing of Final Patient in ACHIEVE Safety Cohort
01/30/23 TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division
01/20/23 TC BioPharm to Host Shareholder Update Call
01/19/23 TC BioPharm Receives Notice of Non-compliance with NASDAQ's Listing Rule 5550(b)(1)
01/17/23 TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
12/12/22 TC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update
11/30/22 TC BioPharm Announces Closing of $7.35 Million Private Placement
11/28/22 TC BioPharm Announces $7.35 Million Private Placement
11/22/22 TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid Leukemia
11/21/22 TC Biopharm (Holdings) Plc's (NASDAQ:TCBP) biggest owners are individual investors who got richer after stock soared 11% last week
10/26/22 TC BioPharm Announces Key Additions to Scientific Advisory Board, Expanding Cell Therapy Expertise
10/03/22 TC BioPharm to Present at Upcoming Investor Conferences
09/13/22 TC BioPharm Receives MHRA Approval for 18-Month Extrapolated Shelf-Life of Allogeneic Cell Therapy Product, OmnImmune®
TCBP Chatroom

User Image donotfollowFoff Posted - 4 minutes ago

$TCBP junk

User Image iPipediCarly Posted - 31 minutes ago

$TCBP I've been watching this since the start of the new year and the amount of fuckery this stock does is wilder than a season of jersey shore. When there's a lot of weird shit going on though, that's usually a sign a pump is among us

User Image mmushonga Posted - 43 minutes ago

$TCBP Im shiting bricks here, folks. I was all in. Have we been played?

User Image Stocktelligence Posted - 57 minutes ago


User Image Insider666 Posted - 1 hour ago

$TCBP It is a scam!!!

User Image AshleySchaeffer_BMW Posted - 1 hour ago

@SparkySC 5 years out 5$ strike, Feb 28 expiry $TCBP

User Image M1Tanker Posted - 1 hour ago

$TCBP pfft

User Image AshleySchaeffer_BMW Posted - 2 hours ago

$TCBP added all the warrants today, 7s are a steal!!

User Image eTXtrd1 Posted - 2 hours ago

$TCBP where’s all the “beaten down, oversold, undervalued” pumpers?!? Come do your thing! 🤪😂

User Image DinamoZagreb007 Posted - 2 hours ago


User Image Fishbanger51 Posted - 2 hours ago

$TCBP time to dollar cost average

User Image Fletcherxonly Posted - 2 hours ago

$TCBP why the drop? Was thinking about jumping in..

User Image allgoodstill Posted - 2 hours ago

$TCBP From $5 to .05.

User Image NokiaYOLOCalls Posted - 2 hours ago

$TCBP No way😐

User Image Market_Magician Posted - 2 hours ago

$TCBP only solace here is that it is on super low volume.

User Image Endalykt Posted - 2 hours ago


User Image Hkelly Posted - 2 hours ago

$TCBP can’t believe, nobody want to buy 😅

User Image Djinn88 Posted - 2 hours ago

$TCBP Such a POS. Down on green and even more on red days 🤣🤣🤣🤣

User Image Market_Magician Posted - 2 hours ago

$TCBP this POS is done.

User Image ShadedThorn Posted - 2 hours ago

$TCBP are you fucking kidding me

User Image staywild Posted - 2 hours ago

$TCBP can only imagine this will go down until of q1 before reversing unless they send it next week to end q1 on a high note

User Image Fishbanger51 Posted - 2 hours ago

$TCBP 52 week low

User Image Endalykt Posted - 3 hours ago

$TCBP shitshow🤮

User Image NokiaYOLOCalls Posted - 3 hours ago


User Image Kelly12 Posted - 3 hours ago

$TCBP prefer companies that have big Pharma ownership ….. any suggestions? This is dead money for now?

User Image RB26LOVER Posted - 3 hours ago

$TCBP can I have some at 2.50 please !!!

User Image Moraldole Posted - 4 hours ago

$TCBP how low can she go? 🙄

User Image PennyStockGod1 Posted - 5 hours ago

$PMEDF PR OUT!!! This thing is gonna explode… So undervalued and not found yet… AI play with only 7.6mil float currently trading at .10 😱 $PIXY $WISA $TCBP $HUBC

User Image risenhoover Posted - 6 hours ago

$TCBP TCBP / TC BioPharm (Holdings) Ltd Price Target Updated https://fintel.io/sfo/us/tcbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image ChartMill Posted - 10 hours ago

$TCBP is expected to show a strong revenue growth of 2786.48% yearly. https://www.chartmill.com/stock/quote/TCBP/fundamental-analysis?key=d61d7701-b02a-4522-ab56-8262512d7c7c&utm_source=stocktwits&utm_medium=FA&utm_content=TCBP&utm_campaign=social_tracking

Analyst Ratings
HC Wainwright & Co. Buy Jan 26, 23
EF Hutton Buy Mar 28, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Randall Mark Edward 10% Owner 10% Owner Nov 30 Buy 5 70,000 350,000 382,963 01/11/23
Randall Kenneth Edward 10% Owner 10% Owner Nov 30 Buy 5 70,000 350,000 382,963 01/11/23
Renaissance Capital Partners L... 10% Owner 10% Owner Nov 30 Buy 5 70,000 350,000 136,834 01/11/23
Randall Kenneth Edward 10% Owner 10% Owner May 24 Buy 1.15 20,803 23,923 100,418 07/14/22